PEAK6 Investments LLC Takes Position in Envista Holdings Co. (NYSE:NVST)

PEAK6 Investments LLC purchased a new stake in Envista Holdings Co. (NYSE:NVST - Free Report) in the third quarter, according to its most recent filing with the SEC. The fund purchased 57,879 shares of the company's stock, valued at approximately $1,144,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in Envista in the third quarter valued at approximately $31,000. GAMMA Investing LLC increased its stake in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock valued at $35,000 after acquiring an additional 726 shares during the period. Huntington National Bank raised its holdings in Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company's stock worth $38,000 after purchasing an additional 949 shares in the last quarter. Blue Trust Inc. lifted its position in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock worth $39,000 after purchasing an additional 804 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its stake in Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock valued at $43,000 after purchasing an additional 728 shares in the last quarter.

Envista Stock Performance

NVST traded down $0.32 during trading on Tuesday, hitting $21.99. The stock had a trading volume of 1,709,126 shares, compared to its average volume of 2,379,750. The firm has a market cap of $3.78 billion, a PE ratio of -2.83, a P/E/G ratio of 3.10 and a beta of 1.31. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $25.64. The company has a 50 day simple moving average of $19.92 and a 200-day simple moving average of $18.33.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.03. The business had revenue of $601.00 million during the quarter, compared to analysts' expectations of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm's revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.43 EPS. Analysts expect that Envista Holdings Co. will post 0.72 EPS for the current year.

Analyst Upgrades and Downgrades

NVST has been the subject of several research reports. Robert W. Baird raised their target price on Envista from $17.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, October 31st. Leerink Partnrs raised shares of Envista from a "strong sell" rating to a "hold" rating in a research note on Thursday, October 31st. JPMorgan Chase & Co. lowered shares of Envista from an "overweight" rating to a "neutral" rating and cut their price target for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Leerink Partners raised shares of Envista from an "underperform" rating to a "market perform" rating and raised their price objective for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Finally, Wells Fargo & Company initiated coverage on shares of Envista in a research note on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 target price on the stock. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.71.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.